Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

43.66

EPS This/Next Y

1.75

Price

1.08

Target Price

Analyst Recom

Performance Q

-79.55

Relative Volume

0.06

Beta

0.74

Ticker: EYEN

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-03-21	EYEN	1.38	0.27	999.99	11992
2025-03-24	EYEN	1.34	0.27	999.99	11992
2025-03-25	EYEN	1.33	0.27	999.99	11992
2025-03-26	EYEN	1.26	0.27	999.99	11992
2025-03-27	EYEN	1.23	0.27	999.99	11992
2025-03-28	EYEN	1.13	N/A	N/A	0
2025-03-31	EYEN	1.11	N/A	N/A	0
2025-04-01	EYEN	1.129	N/A	N/A	0
2025-04-02	EYEN	1.175	N/A	N/A	0
2025-04-03	EYEN	1.12	N/A	N/A	0
2025-04-04	EYEN	0.9821	N/A	N/A	0
2025-04-07	EYEN	0.9251	N/A	N/A	0
2025-04-08	EYEN	0.94	N/A	N/A	0
2025-04-09	EYEN	0.95	N/A	N/A	0
2025-04-10	EYEN	0.9677	N/A	N/A	0
2025-04-11	EYEN	0.9663	N/A	N/A	0
2025-04-14	EYEN	1.0145	N/A	N/A	0
2025-04-15	EYEN	1.12	N/A	N/A	0
2025-04-16	EYEN	1.0913	N/A	N/A	0
2025-04-17	EYEN	1.11	N/A	N/A	0
2025-04-18	EYEN	1.08	N/A	N/A	0
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-03-21	EYEN	1.34	37.5	-	-0.59
2025-03-24	EYEN	1.32	37.5	-	-0.59
2025-03-25	EYEN	1.33	37.5	-	-0.59
2025-03-26	EYEN	1.26	37.5	-	-0.59
2025-03-27	EYEN	1.23	37.5	-	-0.59
2025-03-28	EYEN	1.13	37.5	-	-0.59
2025-03-31	EYEN	1.10	37.5	-	-0.59
2025-04-01	EYEN	1.13	37.5	-	-0.59
2025-04-02	EYEN	1.18	37.5	-	-0.59
2025-04-03	EYEN	1.12	37.5	-	-0.59
2025-04-04	EYEN	0.96	37.5	-	-0.59
2025-04-07	EYEN	0.92	37.5	-	-0.59
2025-04-08	EYEN	0.92	37.5	-	-0.59
2025-04-09	EYEN	0.96	37.5	-	-0.59
2025-04-10	EYEN	0.97	37.5	-	-0.59
2025-04-11	EYEN	0.93	37.5	-	-0.59
2025-04-14	EYEN	1.01	37.5	-	-0.59
2025-04-15	EYEN	1.12	37.5	-	-0.59
2025-04-16	EYEN	1.09	37.5	-	-0.59
2025-04-17	EYEN	1.08	37.5	-	-0.59
2025-04-18	EYEN	1.08	37.5	-	-16.15
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-03-21	EYEN	0.00	-56.08	11.35
2025-03-24	EYEN	0.00	-55.93	11.35
2025-03-25	EYEN	0.00	-55.93	11.35
2025-03-26	EYEN	0.00	-55.93	6.65
2025-03-27	EYEN	0.00	-55.93	6.65
2025-03-28	EYEN	0.00	-55.93	6.65
2025-03-31	EYEN	0.00	-55.93	6.65
2025-04-01	EYEN	0.00	-55.93	6.65
2025-04-02	EYEN	0.00	-55.93	6.65
2025-04-03	EYEN	0.00	-55.93	6.65
2025-04-04	EYEN	0.00	-55.93	6.65
2025-04-07	EYEN	0.00	-55.93	6.65
2025-04-08	EYEN	0.00	-55.93	6.65
2025-04-09	EYEN	0.00	-55.93	6.65
2025-04-10	EYEN	0.00	-55.93	5.92
2025-04-11	EYEN	0.00	-55.93	5.92
2025-04-14	EYEN	0.00	-55.93	5.92
2025-04-15	EYEN	0.00	-55.93	5.92
2025-04-16	EYEN	0.00	-55.93	5.92
2025-04-17	EYEN	0.00	-55.93	5.92
2025-04-18	EYEN	0.00	-55.93	0
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

-0.09

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

-55.93

Beta

0.74

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

99.8

Max Drawdown 5-Year %

-99.8

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

-61.97

Average EPS Est. Cur. Y

-16.15

EPS Next Y. (Est.)

-14.4

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-86888.57

Relative Volume

0.06

Return on Equity vs Sector %

360.4

Return on Equity vs Industry %

373.8

EPS 1 7Days Diff

-15.6

EPS 1 30Days Diff

-15.58

EBIT Estimation

Eyenovia, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 13

Eyenovia, Inc., a commercial-stage ophthalmic pharmaceutical technology company, engages in developing a pipeline of microdose array print therapeutics. It focuses on commercializing Mydcombi (tropicamide and phenylephrine HCL ophthalmic spray) for inducing mydriasis for routine diagnostic procedures and in conditions where short term pupil dilation is desired, and clobetasol propionate ophthalmic suspension for the treatment of post-operative pain and inflammation following ocular surgery. The company is also developing the Optejet delivery system for use in combination with its drug-device therapeutic programs and for out-licensing for use in combination with therapeutics for additional indications. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine, MicroLine, and Mydcombi in China and South Korea; and Senju Pharmaceutical Co., Ltd. to develop and commercialize MicroPine, MicroLine, and Mydcombi. The company has agreement with Formosa Pharmaceuticals. Inc. for Co-Development of Clobetasol Propionate Ophthalmic Suspension (0.05%) for the Treatment of Acute Dry Eye Disease in the U.S. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was incorporated in 2014 and is based in New York, New York.

stock quote shares EYEN – Eyenovia Inc Stock Price stock today

news today EYEN – Eyenovia Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch EYEN – Eyenovia Inc yahoo finance google finance

stock history EYEN – Eyenovia Inc invest stock market

stock prices EYEN premarket after hours

ticker EYEN fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: EYEN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y